Review of photodynamic therapy

Surgeon

Volumn 4, Issue 4, 2006, Pages 231-236

  Awan, M A ^a   Tarin, S A ^a  

^a Wolverhampton Eye Infirmary   (United Kingdom)

Author keywords

Photodynamic; Porfimer; Therapy; Verteporfin

Indexed keywords

BENZOPORPHYRIN DERIVATIVE; PHOTOFRIN; PLACEBO; PORPHYRIN DERIVATIVE;

ARTERY INTIMA PROLIFERATION; ARTHRITIS; ASTHENIA; AUTOIMMUNE DISEASE; BACKACHE; BARRETT ESOPHAGUS; BASAL CELL CARCINOMA; BLEPHARITIS; BONE MARROW PURGING; BRAIN TUMOR; BRONCHUS CANCER; CATARACT; CHOROID MELANOMA; CONJUNCTIVITIS; CONSTIPATION; DIGESTIVE SYSTEM CANCER; DISEASE SEVERITY; DRUG ABSORPTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG PENETRATION; DRUG SAFETY; DRY EYE; EYE DISEASE; FEVER; FLU LIKE SYNDROME; GASTROINTESTINAL DISEASE; HUMAN; INTRAOCULAR TUMOR; LUNG CANCER; LUNG SURGERY; MEDICAL LITERATURE; MEDLINE; MELANOMA; OCULAR PRURITUS; OPHTHALMOLOGY; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY; PROSTATE CANCER; PSORIASIS; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; SKIN CANCER; SKIN DISEASE; SUBRETINAL NEOVASCULARIZATION; THORAX PAIN; TREATMENT OUTCOME; VIRUS INACTIVATION; VISUAL IMPAIRMENT; VITREOUS HEMORRHAGE;

EID: 33746716794     PISSN: 1479666X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1479-666X(06)80065-X     Document Type: Review

References (32)

1. Scott LJ, Goa KL. Verteporfin. Drugs Aging 2000; 16(2):139-48.
2. Novartis Ophthalmics. Visudyne: Product monograph. 2004; Revised Ed.
3. Axca Pharma Inc. Photofrin: Product monograph. 2003; Revised Ed.
4. Schmidt-Erfurth U, Bauman W, Gragoudas E, Flotte TJ, Michaud NA, Birngruber R, et al. Photodynamic therapy of experimental choroidal melanoma using lipoprotein delivered benzoporphyrin. Ophthalmology 1994;101(1):89-99.
5. Ller JW, Schmidt-Erfurth U, Sickenberg M, Pournaras CJ, Laqua H, Barbazetto I, et al. Photodynamic therapy with Verteporfin for choroidal neovascularisation caused by age related macular degeneration: results of a single treatment in a phase 1 and 2 study. Arch Ophthalmol 1999;117(9):1161-73.
6. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal chloroidal neovascularisation in age-related macular degeneration with verteporfin. One year results of 2 randomised clinical trials - TAP Report 1. Arch Ophthalmol 1999;117(10):1329-45.
7. Bressler NM. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularisation in age-related macular degeneration with verteporfin 2- Years results of 2 randomised clinical trials - TAP Report 2. Arch Ophthalmol 2001; 119(2):198-207.
8. Blumenkranz MS, Bressler NM, Bressler SB, Donati G, Fish GE, Haynes LA et al. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularisation in age-related macular degeneration with verteporfin. Three-year results of an open-label extension of 2 randomised clinical trials - TAP Report No. 5. Arch Ophthalmol 2002;120(10):1307-14.
9. Schmidt-Erfurth U, Hasan T. Mechanisms of action of photodynamic therapy with verteporfin for the treatment of age-related macular degeneration. Surv Ophthalmol 2000;45(3): 195-214.
10. Verteporfin in Photodynamic Therapy Study Group. Photodynamic therapy of subfoveal choroidal neovascularisation in pathologic myopia with Verteporfin: 1 year results of a randomised clinical trial-VIP report no 1. Ophthalmology 2001;108(5):841-52.
11. Young LH, Howard MA, Hu LK, Kim RY, Gragoudas ES. Photodynamic therapy of pigmented choroidal melanomas using a liposomal preparation of benzoporphyrin derivative. Arch Ophthalmol 1996;114(2):186-92.
12. Kim RY, Hu LK. Foster BS, Gragoudas ES, Young LH. Photodynamic therapy of pigmented choroidal melanomas of greater than 3-mm thickness. Ophthalmology 1996;103(12): 2029-36.
13. Schmidt-Erfurth U, Flotte TJ, Gragoudas ES, Schomacker K, Birngruber R, Hasan T. Benzoporphyrin-lipoprotein mediated photodestruction of intraocular tumours. Exp Eye Res 1996;62(1): 1-10.
14. Schmidt-Erfurth U, Diddens H, Birngruber R, Hasan T. Photodynamic targeting of human retinoblastoma cells using covalent low-density lipoprotein conjugates. Br J Cancer 1997;75(1):54-61.
15. Husain D, Miller JW, Kenney AG, Michaud N, Flotte TJ, Gragoudas ES. Photodynamic theraphy and digital angiography of experimental iris neovascularisation using liposomal benzoporphyrin derivative. Ophthalmology 1997;104(8):1242-50.
16. Schmidt-Erfurth U, Hasan T, Schomacker K, Flotte T, Birngruber R. In vivo uptake of liposomal benzoporphyrin derivative and photothrombosis in experimental corneal neovascularisation. Lasers Surg Med 1995;17(2):178-188.
17. Hoerauf H, Huttmann G, Diddens H, Thiele B, Laqua H. Photodynamic therapy of eyelid basalioma after topical administration of delta-aminolevulinic acid. Ophthalmologe 1994;91(6):824-29.
18. Sickenberg M, Schmidt-Erfurth U, Miller JW, Pournaras CJ, Zografos L, Piguet B, et al. A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes. Arch Ophthalmol 2000;118(3): 327-36.
19. McCaughan JS Jr. Photodynamic therapy: a review. Drugs Aging 1999;15(1):49-68.
20. Tetsuya et al. Pre-operative PDT for lung cancer. Photodynamics News 1999;2:1461.
21. Busetti A, Soncin M, Jori G, Rodgers MA. High efficiency of benzoporphyrin derivative in the photodynamic therapy of pigmented malignant melanoma. Br J Cancer 1999;79(5-6): 821-24.
22. Momma T, Hamblin MR, Wu HC, Hasan T. Photodynamic therapy of orthotopic prostate cancer with benzoporphyrin derivative: local control and distant metastasis. Cancer Res 1998;58(23):5425-31.
23. Lui H. Photodynamic therapy in dermatology with porfimer sodium and benzoporphyrin derivative: an update. Semin Oncol 1994;21(6 Suppl 15): 11-14.
24. Boehncke WH, Elshorst-Schmidt T, Kaufmann R. Systemic photodynamic therapy is a safe and effective treatment for psoriasis. Arch Dermatol 2000;136(2):271-72.
25. Senior K, Brophy S. A light at the end of the tunnel for psoriasis sufferers? Mol Med Today 1998;4(10):416.
26. Obochi MO, Ratkay LG, Levy JG. Prolonged skin allograft survival after photodynamic therapy associated with modification of donor skin antigenicity. Transplantation 1997;63(6): 810-17.
27. Hendrich C, Huttmann G, Vispo-Seara JL, Houserek S, Siebert WE. Experimental photodynamic laser therapy for rheumatoid arthritis with a second generation photosensitizer. Knee Surg Sports Traumatol Arthrosc 2000;8(3):190-94.
28. Chowdhary RK, Ratkay LG, Canaan AJ, Waterfield JD, Richter AM, Levy JG. Uptake of verteporfin by articular tissues following systemic and intra-articular administration. Biopharm Drug Dispos 1998;19(6):395-400.
29. Mulroney CM, Gluck S, Ho AD. The use of photodynamic therapy in bone marrow purging. Semin Oncol 1994; 2(6 Suppl 15): 24-27.
30. Turnbull RG, Chen JC, Labow RS, Margaron P, Hsiang YN. Benzoporphyrin derivative monacid ring A (Verteporfin) alone has no inhibitory effect on intimal hyperplasia: in vitro and in vivo results. J Invest Surg 2000;13(3):153-59.
31. Levy JG. Photosensitizers in photodynamic therapy. Semin Oncol 1994;2(6 Suppl 15): 4-10.
32. Leong S, Chan AH, Levy JG, Hunt DW. Transcutaneous photodynamic therapy alters the development of an adoptively transferred form of murine experimental autoimmune encephalomyelitis. Photochem Photobiol 1996;64(5): 751-57.